AI-powered clinical trials and the imperative for regulatory transparency and accountability

The transformative impact of Artificial intelligence (AI) on clinical trials is explored. To identify the potential benefits of AI in enhancing both the efficiency and effectiveness of clinical research, while also examining the challenges associated with its implementation.

Through an analysis of research literature, case studies, and relevant regulatory frameworks, which highlights the potential of AI in clinical research. This includes improvements in patient recruitment, streamlined data analysis, and optimized clinical trial design. Case studies are presented to showcase the effectiveness of AI in achieving better trial outcomes.

Challenges that come with implementing AI such as issues regarding accountability and transparency due to increased reliance on AI-driven insights. Additionally, regulatory uncertainties around approving and overseeing AI-powered clinical trials, and ethical considerations concerning data privacy and potential biases within AI algorithms, are identified. Despite these challenges, the research emphasizes AI's potential to transform drug development by making clinical trials more efficient and insightful.

The paper concludes by suggesting future research directions that explore the ethical, legal, and regulatory implications of AI in clinical trials, while further investigating its potential benefits for medical advancements.